Skip to Content

GSI 7977 (Sovaldi 400 mg)

Generic Name: sofosbuvir

Pill with imprint GSI 7977 is Yellow, Capsule-shape and has been identified as Sovaldi 400 mg. It is supplied by Gilead Sciences, Inc..

Sovaldi is used in the treatment of hepatitis c and belongs to the drug class miscellaneous antivirals. There is no proven risk in humans during pregnancy. In combination with Ribavirin or Peginterferon Alfa/Ribavirin: Not for use in pregnancy. Sovaldi 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 7977

Sovaldi

Generic Name:
sofosbuvir
Imprint:
GSI 7977
Strength:
400 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antivirals
Pregnancy Category:
B - No proven risk in humans
X - Not for use in pregnancy - in combination with Ribavirin or Peginterferon Alfa/Ribavirin
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-1501

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide